NOVOCURE LTD - NOTE 11/0

CUSIP: 67011XAB9

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Debt / NOTE 11/0
Market price (% of par)
91.13%
Total 13F principal
$546,867,200
Principal change
+$29,291,200
Total reported market value
$497,798,182
Number of holders
45
Value change
+$25,492,803
Number of buys
28
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 67011XAB9?
CUSIP 67011XAB9 identifies 67011XAB9 - NOVOCURE LTD - NOTE 11/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q1 2022

As of 31 Mar 2022, NOVOCURE LTD - NOTE 11/0 was held by 45 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $546,867,200 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, STEELHEAD PARTNERS LLC, DeepCurrents Investment Group LLC, Verition Fund Management LLC, D. E. Shaw & Co., Inc., BANK OF AMERICA CORP /DE/, CAPSTONE INVESTMENT ADVISORS, LLC, Balyasny Asset Management LLC, and Aequim Alternative Investments LP. This page lists 45 institutional bondholders reporting positions for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.